Alembic Pharmaceuticals Ltd (BOM:533573)
₹ 1115.3 -31.2 (-2.72%) Market Cap: 219.23 Bil Enterprise Value: 223.16 Bil PE Ratio: 34.28 PB Ratio: 4.47 GF Score: 91/100

Q4 2020 Alembic Pharmaceuticals Ltd Earnings Call Transcript

Apr 23, 2020 / 10:30AM GMT
Release Date Price: ₹698.55 (+9.56%)
Operator

Ladies and gentlemen, good day, and welcome to the Alembic Pharmaceuticals Limited Q4 FY '20 or Annual Unaudited Financial Results Conference Call. We have with us on the phone, Mr. Pranav Amin, Managing Director; Mr. Shaunak Amin, Managing Director; Mr. Mitanshu Shah, Head, Finance; Mr. Ajay Kumar Desai, Senior VP, Finance; and Mr. Jesal Shah, Head, Strategy. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Pranav Amin, Managing Director. Thank you, and over to you, sir.

Pranav Chirayu Amin
Alembic Pharmaceuticals Limited - MD & Executive Director

Thank you, Margaret. Good evening, everyone, and thank you for joining the fourth quarter results conference call. I'm sure you have received the unaudited financial results by now. Since the auditors are based in Mumbai, they faced challenges completing the audit during this lockdown period. We will, however -- we have, however, published -- we will publish the audited accounts whenever the situation returns to normal. However, in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot